Nordic Lymphoma Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Aarhus Denmark (2004)

Organization Overview

First Clinical Trial
2004
NCT01016795
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Nordic Lymphoma Group